{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-296870","form_type":"8-K","ticker":null,"cik":"0001832415","company_name":"Better Therapeutics, Inc.","filed_at":"2023-12-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.863403+00:00","generated_at":"2026-06-07T11:26:11.489248+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Better Therapeutics receives Nasdaq delisting notice; intends to appeal","bullets":["Nasdaq notified Better Therapeutics on Dec 14, 2023 of delisting effective Dec 26, 2023 due to continued non-compliance with minimum bid price ($1.00) and MVLS ($35M) requirements.","Company had 180-day compliance period ending Dec 13, 2023 but failed to regain compliance; not eligible for additional extension.","Company intends to appeal to a Nasdaq Hearings Panel before Dec 21, 2023; appeal will stay delisting pending panel decision.","No assurance that appeal will succeed or that listing on Nasdaq Capital Market will be maintained."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-296870","json":"https://secwatch.observer/filing/0001193125-23-296870.json","markdown":"https://secwatch.observer/filing/0001193125-23-296870.md","text":"https://secwatch.observer/filing/0001193125-23-296870.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832415/000119312523296870/0001193125-23-296870-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832415/000119312523296870/d48627d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T11:26:11.489248+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3fe43264a06e5a6ec2c87f35dece15406ca75459","claim":"Better Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5550(b)(2)).","evidence_excerpt":"continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires companies listed on the Nasdaq Capital Market to maintain a minimum bid price of at least $1 per share (the “Minimum Bid Price Requirement”). Nasdaq Listing Rule 5550(b)(2) requires companies listed on the Nasdaq Capital Market to maintain a minimum market value of listed","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832415/000119312523296870/0001193125-23-296870-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2), 5550(b)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}